PortfoliosLab logo
SGMT vs. PRCT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SGMT and PRCT is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

SGMT vs. PRCT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sagimet Biosciences Inc. (SGMT) and PROCEPT BioRobotics Corporation (PRCT). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%150.00%OctoberNovemberDecember2025FebruaryMarch
-76.55%
57.86%
SGMT
PRCT

Key characteristics

Sharpe Ratio

SGMT:

-0.24

PRCT:

0.29

Sortino Ratio

SGMT:

0.38

PRCT:

1.08

Omega Ratio

SGMT:

1.04

PRCT:

1.12

Calmar Ratio

SGMT:

-0.29

PRCT:

0.42

Martin Ratio

SGMT:

-0.77

PRCT:

1.17

Ulcer Index

SGMT:

32.35%

PRCT:

15.76%

Daily Std Dev

SGMT:

106.29%

PRCT:

64.69%

Max Drawdown

SGMT:

-86.59%

PRCT:

-63.51%

Current Drawdown

SGMT:

-79.70%

PRCT:

-42.06%

Fundamentals

Market Cap

SGMT:

$120.41M

PRCT:

$3.16B

EPS

SGMT:

-$0.39

PRCT:

-$1.75

Total Revenue (TTM)

SGMT:

$0.00

PRCT:

$224.50M

EBITDA (TTM)

SGMT:

-$36.26M

PRCT:

-$81.99M

Returns By Period

In the year-to-date period, SGMT achieves a -16.89% return, which is significantly higher than PRCT's -28.44% return.


SGMT

YTD

-16.89%

1M

-17.80%

6M

0.54%

1Y

-13.43%

5Y*

N/A

10Y*

N/A

PRCT

YTD

-28.44%

1M

-13.00%

6M

-28.96%

1Y

20.82%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SGMT vs. PRCT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGMT
The Risk-Adjusted Performance Rank of SGMT is 4040
Overall Rank
The Sharpe Ratio Rank of SGMT is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of SGMT is 4747
Sortino Ratio Rank
The Omega Ratio Rank of SGMT is 4646
Omega Ratio Rank
The Calmar Ratio Rank of SGMT is 3333
Calmar Ratio Rank
The Martin Ratio Rank of SGMT is 3434
Martin Ratio Rank

PRCT
The Risk-Adjusted Performance Rank of PRCT is 6666
Overall Rank
The Sharpe Ratio Rank of PRCT is 6363
Sharpe Ratio Rank
The Sortino Ratio Rank of PRCT is 6767
Sortino Ratio Rank
The Omega Ratio Rank of PRCT is 6262
Omega Ratio Rank
The Calmar Ratio Rank of PRCT is 7070
Calmar Ratio Rank
The Martin Ratio Rank of PRCT is 6565
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SGMT vs. PRCT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sagimet Biosciences Inc. (SGMT) and PROCEPT BioRobotics Corporation (PRCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for SGMT, currently valued at -0.24, compared to the broader market-3.00-2.00-1.000.001.002.003.00-0.240.29
The chart of Sortino ratio for SGMT, currently valued at 0.38, compared to the broader market-4.00-2.000.002.004.000.381.08
The chart of Omega ratio for SGMT, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.12
The chart of Calmar ratio for SGMT, currently valued at -0.29, compared to the broader market0.001.002.003.004.005.00-0.290.42
The chart of Martin ratio for SGMT, currently valued at -0.77, compared to the broader market-10.000.0010.0020.00-0.771.17
SGMT
PRCT

The current SGMT Sharpe Ratio is -0.24, which is lower than the PRCT Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of SGMT and PRCT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00OctoberNovemberDecember2025FebruaryMarch
-0.24
0.29
SGMT
PRCT

Dividends

SGMT vs. PRCT - Dividend Comparison

Neither SGMT nor PRCT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SGMT vs. PRCT - Drawdown Comparison

The maximum SGMT drawdown since its inception was -86.59%, which is greater than PRCT's maximum drawdown of -63.51%. Use the drawdown chart below to compare losses from any high point for SGMT and PRCT. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2025FebruaryMarch
-79.70%
-42.06%
SGMT
PRCT

Volatility

SGMT vs. PRCT - Volatility Comparison

Sagimet Biosciences Inc. (SGMT) has a higher volatility of 19.89% compared to PROCEPT BioRobotics Corporation (PRCT) at 18.85%. This indicates that SGMT's price experiences larger fluctuations and is considered to be riskier than PRCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%OctoberNovemberDecember2025FebruaryMarch
19.89%
18.85%
SGMT
PRCT

Financials

SGMT vs. PRCT - Financials Comparison

This section allows you to compare key financial metrics between Sagimet Biosciences Inc. and PROCEPT BioRobotics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items